Skip to main content
Overview
News
Events & Presentations
IRA Commentary
Royalty Duration
Stock Info
Stock Quote
Analyst Coverage
Financials
Quarterly Results
Annual Report
SEC Filings
Governance
Governance Documents
Executive Management
Board of Directors
Resources
Investor FAQs
Investor Email Alerts
Investor Contact
IRA Commentary
Halozyme Statement on Proposed Rule for IPAY 2029
Halozyme Letter to CMS on IRA IPAY 2028
Comparison Medicare Expenditure for SC versus IV Drugs
Patient Experience: SC Treatment